|
|
|
| Efficacy of Ceftriaxone Sodium Combined with Dexamethasone in the Treatment of Children with Purulent Meningitis and Its Effects on Serum IFN-γ and IL-4 Levels |
| ZHANG Jingjing, JIA Yuanyuan, HU Miaomiao, et al |
| The First Affiliated Hospital of the Military Medical University of the Chinese People's Liberation Army Air Force, Shaanxi Xi'an 710032, China |
|
|
|
|
Abstract Objective: To observe the efficacy of ceftriaxone sodium combined with dexamethasone in the treatment of purulent meningitis (PM) in children and the effects on levels of serum interferon (IFN-γ) and interleukin 4 (IL-4). Methods: Using the random remainder grouping method of random number table method, 96 children with PM who were admitted to the hospital from March 2019 to March 2022 were randomly divided into the observation group and the control group, with 48 cases in each group. Both groups were given basic symptomatic treatment, and the control group underwent ceftriaxone sodium therapy additionally while the observation group underwent ceftriaxone sodium + dexamethasone therapy additionally, and both group were treated for 2 weeks. After 2 weeks of treatment, the clinical efficacy and recovery status of symptoms and signs of the two groups were compared, and the levels of inflammatory factors and serum related factors were observed in the two groups before and after treatment. Results: After 2 weeks of treatment, the total clinical effective rate of the observation group was higher than that of the control group (97.92% VS 87.50%) (P<0.05). The fever abatement time, cerebrospinal fluid recovery time and recovery time of peripheral blood leukocyte of (2.34±0.76) d, (7.65±0.83) d and (5.24±1.27) d in the observation group were shorter than (3.62±0.81) d, (9.88±1.12) d and (7.18±2.03) d in the control group (P<0.05). After 2 weeks of treatment, serum levels of INF-γ, IL-4, TNF-α, PCT, MMP-9 and sB7-H3 in the two groups were lower than those before treatment, and the differences before and after treatment were statistically significant between the observation group [(4.31±1.08) pg/mL, (53.54±4.17) pg/mL, (91.85±19.90) ng/L, (12.51±2.68) ng/mL, (251.09±24.07) μg/L, (1850.66±269.54) ng/L] and the control group [(2.97±1.38) pg/mL, (45.83±0.38) pg/mL, (75.98±20.76) ng/L, (8.76±2.79) ng/mL, (204.51±18.88) μg/L, (1320.23±240.71) ng/L] (P<0.05). Conclusion: Ceftriaxone sodium+dexamethasone can shorten the recovery times of symptoms and signs, reduce the levels of inflammatory factors, and promote the rehabilitation of children with PM.
|
|
|
|
|
|
[1] 胡田田,陶艳玲.达托霉素用于治疗缓症链球菌血症并化脓性脑膜炎1例[J].中国感染与化疗杂志,2022,22(2):220-222.
[2] 王利萍.地塞米松联合头孢曲松钠在化脓性脑膜炎患儿治疗中的效果分析[J].实用医技杂志,2021,28(6):821-822.
[3] 胡亚美,江载芳.诸福棠实用儿科学[M].第8版.北京:人民卫生出版社,2012.15-16.
[4] 郑丽娇,刘波,何丽.利奈唑胺联合头孢曲松对GBS感染所致化脓性脑膜炎患儿脑脊液NSE,BMP,hs-CRP表达水平的影响[J].热带医学杂志,2021,21(4):512-515.
[5] 吴海侠,冯启蒙,黄秀秀,等.抗菌药物及地塞米松鞘内注射联合醒脑静注射液治疗小儿化脓性脑膜炎的疗效及对血清基质金属蛋白酶-9、可溶性B7同源体3的影响[J].世界临床药物,2021,42(8):658-663,694.
[6] 郭峰,杨理明.头孢曲松钠联合地塞米松治疗小儿化脓性脑膜炎的临床分析[J].国际神经病学神经外科学杂志,2020,47(5):503-506.
[7] 孙霞,王丽,李庭毅.可溶性Tim-3及Galectin-9在结核性脑膜炎患者脑脊液中的表达及意义[J].国际检验医学杂志,2020,41(22):2721-2724,2731.
[8] 李兴广,吴海侠.地塞米松辅助治疗小儿难治性化脓性脑膜炎的临床疗效及对患儿血清CRP、PCT、TNF-α、NO和H_2S水平的影响[J].脑与神经疾病杂志,2020,28(4):238-242.
[9] 葛莉.脑脊液及血清PCT,CD64,CRP在脑膜炎患儿中的鉴别诊断价值[J].检验医学与临床,2020,17(7):950-952. |
|
|
|
2022, Vol. 28 
